Cargando…

The treatment of wastewater containing pharmaceuticals in microcosm constructed wetlands: the occurrence of integrons (int1–2) and associated resistance genes (sul1–3, qacEΔ1)

The aim of this study was to analyze the occurrence of sulfonamide resistance genes (sul1–3) and other genetic elements as antiseptic resistance gene (qacEΔ1) and class 1 and class 2 integrons (int1–2) in the upper layer of substrate and in the effluent of microcosm constructed wetlands (CWs) treati...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowrotek, Monika, Kotlarska, Ewa, Łuczkiewicz, Aneta, Felis, Ewa, Sochacki, Adam, Miksch, Korneliusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486623/
https://www.ncbi.nlm.nih.gov/pubmed/28493189
http://dx.doi.org/10.1007/s11356-017-9079-1
_version_ 1783246293265547264
author Nowrotek, Monika
Kotlarska, Ewa
Łuczkiewicz, Aneta
Felis, Ewa
Sochacki, Adam
Miksch, Korneliusz
author_facet Nowrotek, Monika
Kotlarska, Ewa
Łuczkiewicz, Aneta
Felis, Ewa
Sochacki, Adam
Miksch, Korneliusz
author_sort Nowrotek, Monika
collection PubMed
description The aim of this study was to analyze the occurrence of sulfonamide resistance genes (sul1–3) and other genetic elements as antiseptic resistance gene (qacEΔ1) and class 1 and class 2 integrons (int1–2) in the upper layer of substrate and in the effluent of microcosm constructed wetlands (CWs) treating artificial wastewater containing diclofenac and sulfamethoxazole (SMX), which is a sulfonamide antibiotic. The bacteria in the substrate and in the effluents were equipped with the sul1–2, int1, and qacEΔ1 resistance determinants, which were introduced into the CW system during inoculation with activated sludge and with the soil attached to the rhizosphere of potted seedlings of Phalaris arundinacea ‘Picta’ roots (int1). By comparing the occurrence of the resistance determinants in the upper substrate layer and the effluent, it can be stated that they neither were lost nor emerged along the flow path. The implications of the presence of antibiotic resistance genes in the effluent may entail a risk of antibiotic resistance being spread in the receiving environment. Additionally, transformation products of SMX were determined. According to the obtained results, four (potential) SMX transformation products were identified. Two major metabolites of SMX, 2,3,5-trihydroxy-SMX and 3,5-dihydroxy-SMX, indicated that SMX may be partly oxidized during the treatment. The remaining two SMX transformation products (hydroxy-glutathionyl-SMX and glutathionyl-SMX) are conjugates with glutathione, which suggests the ability of CW bacterial community to degrade SMX and resist antimicrobial stress. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11356-017-9079-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5486623
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-54866232017-07-11 The treatment of wastewater containing pharmaceuticals in microcosm constructed wetlands: the occurrence of integrons (int1–2) and associated resistance genes (sul1–3, qacEΔ1) Nowrotek, Monika Kotlarska, Ewa Łuczkiewicz, Aneta Felis, Ewa Sochacki, Adam Miksch, Korneliusz Environ Sci Pollut Res Int Research Article The aim of this study was to analyze the occurrence of sulfonamide resistance genes (sul1–3) and other genetic elements as antiseptic resistance gene (qacEΔ1) and class 1 and class 2 integrons (int1–2) in the upper layer of substrate and in the effluent of microcosm constructed wetlands (CWs) treating artificial wastewater containing diclofenac and sulfamethoxazole (SMX), which is a sulfonamide antibiotic. The bacteria in the substrate and in the effluents were equipped with the sul1–2, int1, and qacEΔ1 resistance determinants, which were introduced into the CW system during inoculation with activated sludge and with the soil attached to the rhizosphere of potted seedlings of Phalaris arundinacea ‘Picta’ roots (int1). By comparing the occurrence of the resistance determinants in the upper substrate layer and the effluent, it can be stated that they neither were lost nor emerged along the flow path. The implications of the presence of antibiotic resistance genes in the effluent may entail a risk of antibiotic resistance being spread in the receiving environment. Additionally, transformation products of SMX were determined. According to the obtained results, four (potential) SMX transformation products were identified. Two major metabolites of SMX, 2,3,5-trihydroxy-SMX and 3,5-dihydroxy-SMX, indicated that SMX may be partly oxidized during the treatment. The remaining two SMX transformation products (hydroxy-glutathionyl-SMX and glutathionyl-SMX) are conjugates with glutathione, which suggests the ability of CW bacterial community to degrade SMX and resist antimicrobial stress. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11356-017-9079-1) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-05-10 2017 /pmc/articles/PMC5486623/ /pubmed/28493189 http://dx.doi.org/10.1007/s11356-017-9079-1 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Article
Nowrotek, Monika
Kotlarska, Ewa
Łuczkiewicz, Aneta
Felis, Ewa
Sochacki, Adam
Miksch, Korneliusz
The treatment of wastewater containing pharmaceuticals in microcosm constructed wetlands: the occurrence of integrons (int1–2) and associated resistance genes (sul1–3, qacEΔ1)
title The treatment of wastewater containing pharmaceuticals in microcosm constructed wetlands: the occurrence of integrons (int1–2) and associated resistance genes (sul1–3, qacEΔ1)
title_full The treatment of wastewater containing pharmaceuticals in microcosm constructed wetlands: the occurrence of integrons (int1–2) and associated resistance genes (sul1–3, qacEΔ1)
title_fullStr The treatment of wastewater containing pharmaceuticals in microcosm constructed wetlands: the occurrence of integrons (int1–2) and associated resistance genes (sul1–3, qacEΔ1)
title_full_unstemmed The treatment of wastewater containing pharmaceuticals in microcosm constructed wetlands: the occurrence of integrons (int1–2) and associated resistance genes (sul1–3, qacEΔ1)
title_short The treatment of wastewater containing pharmaceuticals in microcosm constructed wetlands: the occurrence of integrons (int1–2) and associated resistance genes (sul1–3, qacEΔ1)
title_sort treatment of wastewater containing pharmaceuticals in microcosm constructed wetlands: the occurrence of integrons (int1–2) and associated resistance genes (sul1–3, qaceδ1)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486623/
https://www.ncbi.nlm.nih.gov/pubmed/28493189
http://dx.doi.org/10.1007/s11356-017-9079-1
work_keys_str_mv AT nowrotekmonika thetreatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT kotlarskaewa thetreatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT łuczkiewiczaneta thetreatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT felisewa thetreatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT sochackiadam thetreatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT mikschkorneliusz thetreatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT nowrotekmonika treatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT kotlarskaewa treatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT łuczkiewiczaneta treatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT felisewa treatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT sochackiadam treatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1
AT mikschkorneliusz treatmentofwastewatercontainingpharmaceuticalsinmicrocosmconstructedwetlandstheoccurrenceofintegronsint12andassociatedresistancegenessul13qaced1